louisiana semaglutide digestive blockage class action louisiana glp-1 gastrointestinal obstruction class action A class-action kentucky glp-1 gastrointestinal obstruction class

About 51% of tirzepatide participants developed antidrug antibodies, and those with antibodies had higher rates of injection site reactions, but these were non-serious and transient with no observed differences in drug efficacy

For a patient with a serum vitamin B12 level of 157 pg/mL, what rapid treatment regimen (daily intramuscular injection schedule, followed by weekly and then monthly dosing) can be used to restore normal levels?

11.27.24 Gastrointestinal issues added to Wegovy label The Wegovy warning label has been updated to include data from a clinical trial showing the likelihood of developing severe gastrointestinal issues when using Wegovy for weight loss

By enhancing feelings of fullness and reducing cravings, GLP-1 injections support sustainable weight loss when combined with a healthy lifestyle